Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "ALKEM launches Favipiravir in India under the brand name Alfluenza for the treatment of mild to moderate COVID-19.".
Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "ALKEM launches Favipiravir in India under the brand name Alfluenza for the treatment of mild to moderate COVID-19.".